Viewing Study NCT00126451


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-10 @ 7:25 PM
Study NCT ID: NCT00126451
Status: TERMINATED
Last Update Posted: 2017-04-10
First Post: 2005-08-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module